Prediction and Prevention of Sudden Death in the Brugada Syndrome

Area of Science:

• Cardiology
• Genetics
• Electrophysiology

Background:

• Sudden cardiac death (SCD) from sudden cardiac arrest (SCA) causes over 250,000 US deaths annually, accounting for 50% of cardiovascular mortality.
• Brugada Syndrome (BrS) is an arrhythmogenic channelopathy predisposing asymptomatic individuals to high risk of SCD/SCA as their initial cardiac event.
• Current risk prediction for SCA/SCD faces challenges in identifying high-risk subgroups within the general population.

Purpose of the Study:

• To systematically review qualitative evidence on clinical, electrocardiographic, electrophysiological, and genetic markers for risk stratification in Brugada Syndrome patients.
• To discuss current evidence regarding therapeutic approaches for primary prevention in this patient population.

Main Methods:

• Systematic literature review of qualitative evidence.
• Analysis of proposed clinical, electrocardiographic, electrophysiological, and genetic markers.
• Evaluation of contemporary therapeutic strategies.

Main Results:

• Accurate identification of high-risk asymptomatic BrS patients is crucial for improving SCD prediction algorithms.
• Multiparametric risk scores utilizing validated clinical variables and biomarkers show potential utility.
• Primary prevention therapies may significantly reduce the risk of sudden death in BrS patients.

Conclusions:

• Improved risk stratification in Brugada Syndrome is essential for effective sudden cardiac death prevention.
• Multiparametric risk assessment and targeted primary prevention are key strategies.
• Further research into validated markers and therapies is warranted to reduce mortality.